Are you over 18 and want to see adult content?
More Annotations
![A complete backup of nubedeventas.com](https://www.archivebay.com/archive2/ace7afa5-11c0-4647-972a-6ab762f95885.png)
A complete backup of nubedeventas.com
Are you over 18 and want to see adult content?
![A complete backup of emmachildsart.com](https://www.archivebay.com/archive2/ea94d11e-361f-42cd-8c36-419b0829f00a.png)
A complete backup of emmachildsart.com
Are you over 18 and want to see adult content?
![A complete backup of earthfrenzyradio.com](https://www.archivebay.com/archive2/481a009f-01ac-4ba4-9e82-2fb9a203f4c5.png)
A complete backup of earthfrenzyradio.com
Are you over 18 and want to see adult content?
![A complete backup of culturetourist.com](https://www.archivebay.com/archive2/b85ac512-f165-4520-a122-075576121256.png)
A complete backup of culturetourist.com
Are you over 18 and want to see adult content?
![A complete backup of viewprivatephotos.com](https://www.archivebay.com/archive2/d426a3da-9f28-43f3-9832-4bd7db83bfd9.png)
A complete backup of viewprivatephotos.com
Are you over 18 and want to see adult content?
![A complete backup of spreekuurthuis.nl](https://www.archivebay.com/archive2/75bbb54d-349e-403d-a16f-18f7bddc19c0.png)
A complete backup of spreekuurthuis.nl
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of hplfilmfestival.com](https://www.archivebay.com/archive2/64d7e9bc-435c-45a1-9e71-48fb61b21991.png)
A complete backup of hplfilmfestival.com
Are you over 18 and want to see adult content?
![A complete backup of thorntontomasetti.com](https://www.archivebay.com/archive2/4e66d1a8-fd58-4fa5-a23c-3dd5e7e60c21.png)
A complete backup of thorntontomasetti.com
Are you over 18 and want to see adult content?
![A complete backup of extravaluechecks.com](https://www.archivebay.com/archive2/cd10aaf8-0e4f-42a8-b257-931e3ba29cc4.png)
A complete backup of extravaluechecks.com
Are you over 18 and want to see adult content?
Text
systems.
CANCER STAGING
Staging is the process of determining how much cancer is within the body (tumor size) and if it has spread. Learn about the TNM Staging system and other ways that stage is described. EDUCATION AND TRAINING FOR HEALTH PROFESSIONALS This is a collection of cancer education and training tools from NCI and NIH for health care providers, public health program planners, and cancer registrars. Courses are available in a variety of formats. Note: For information about cancer research fellowships and funding for scientific training IMMUNOTHERAPY FOR CANCER Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.. Immunotherapy is a type of biological therapy.Biological therapy is a type of treatment that uses substances made from living organisms to treat cancer. THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. WHAT DOES MELANOMA LOOK LIKE? Melanoma is a type of cancer that begins in melanocytes (cells that make the pigment melanin).Below are photos of melanoma that formed on the skin. Melanoma can also start in the eye, the intestines, or other areas of the body with pigmented tissues.. Often the first sign of melanoma is a change in the shape, color, size, or feel of an existingmole.
MONOCLONAL ANTIBODIES Monoclonal antibodies can cause side effects, which can differ from person to person. The ones you may have and how they make you feel will depend on many factors, such as how healthy you are before treatment, your type of cancer, how advanced it is, the typeGDC
We detected you are using Internet Explorer. This site is best viewed with Chrome, Edge, or Firefox.ETHYLENE OXIDE
Learn about ethylene oxide, which can raise your risk of lymphoma and leukemia. Exposure may occur through industrial emissions, tobacco smoke, and the use of products sterilized with ethylene oxide, such as certain medical products or cosmetics. DRUGS APPROVED FOR ESOPHAGEAL CANCER This page lists cancer drugs approved by the Food and Drug Administration (FDA) for esophageal cancer. The list includes generic names and brand names. The drug names link to NCI's Cancer IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ weakened immunesystems.
CANCER STAGING
Staging is the process of determining how much cancer is within the body (tumor size) and if it has spread. Learn about the TNM Staging system and other ways that stage is described. EDUCATION AND TRAINING FOR HEALTH PROFESSIONALS This is a collection of cancer education and training tools from NCI and NIH for health care providers, public health program planners, and cancer registrars. Courses are available in a variety of formats. Note: For information about cancer research fellowships and funding for scientific training IMMUNOTHERAPY FOR CANCER Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.. Immunotherapy is a type of biological therapy.Biological therapy is a type of treatment that uses substances made from living organisms to treat cancer. THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. WHAT DOES MELANOMA LOOK LIKE? Melanoma is a type of cancer that begins in melanocytes (cells that make the pigment melanin).Below are photos of melanoma that formed on the skin. Melanoma can also start in the eye, the intestines, or other areas of the body with pigmented tissues.. Often the first sign of melanoma is a change in the shape, color, size, or feel of an existingmole.
MONOCLONAL ANTIBODIES Monoclonal antibodies can cause side effects, which can differ from person to person. The ones you may have and how they make you feel will depend on many factors, such as how healthy you are before treatment, your type of cancer, how advanced it is, the typeGDC
We detected you are using Internet Explorer. This site is best viewed with Chrome, Edge, or Firefox.ETHYLENE OXIDE
Learn about ethylene oxide, which can raise your risk of lymphoma and leukemia. Exposure may occur through industrial emissions, tobacco smoke, and the use of products sterilized with ethylene oxide, such as certain medical products or cosmetics. DRUGS APPROVED FOR ESOPHAGEAL CANCER This page lists cancer drugs approved by the Food and Drug Administration (FDA) for esophageal cancer. The list includes generic names and brand names. The drug names link to NCI's CancerCANCER STAGING
Staging is the process of determining how much cancer is within the body (tumor size) and if it has spread. Learn about the TNM Staging system and other ways that stage is described. EDUCATION AND TRAINING FOR HEALTH PROFESSIONALS This is a collection of cancer education and training tools from NCI and NIH for health care providers, public health program planners, and cancer registrars. Courses are available in a variety of formats. Note: For information about cancer research fellowships and funding for scientific training METASTATIC CANCER: WHEN CANCER SPREADS Metastatic cancer is cancer that spreads from its site of origin to another part of the body. Learn how cancer spreads, possible symptoms, common sites where cancer spreads, and how to find out about treatmentoptions.
STEM CELL TRANSPLANTS IN CANCER TREATMENT Stem cell transplants are procedures that restore blood-forming stem cells in people who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy that are used to treat certain cancers.. Blood-forming stem cells are important because they grow into different types of blood cells.The main types of blood cells are: White blood cells, which are part of your immune R-CHOP - NATIONAL CANCER INSTITUTE Chemotherapy is often given as a combination of drugs.Combinations usually work better than single drugs because different drugs kill cancer cells in different ways.. Each of the drugs in this combination is approved by the Food and Drug Administration (FDA) to treat cancer or conditions related to cancer.. Use in Cancer RADIATION THERAPY SIDE EFFECTS Radiation therapy has side effects because it not only kills or slows the growth of cancer cells, it can also affect nearby healthy cells. Many people who get radiation therapy experience fatigue. Other side effects depend on the part of the body that is being treated. Learn more about possible side effects. NCI DICTIONARY OF CANCER TERMS NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine. MONOCLONAL ANTIBODIES Monoclonal antibodies can cause side effects, which can differ from person to person. The ones you may have and how they make you feel will depend on many factors, such as how healthy you are before treatment, your type of cancer, how advanced it is, the type CHEMOTHERAPY AND YOU www.cancer.gov. 1. Questions and Answers about Chemotherapy. What is chemotherapy? Chemotherapy (also called chemo) is a type of cancer treatment that uses drugs to destroy cancer cells. SUPPORT FOR PEOPLE WITH CANCER: CANCER PAIN CONTROL Cancer Pain Control. Cancer pain can be managed. Having cancer doesn’t mean that you’ll have pain. But if you do, you can manage most of your pain with medicine and other treatments. IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ weakened immunesystems.
CANCER STAGING
Most staging systems include information about: Where the tumor is located in the body. The cell type (such as, adenocarcinoma or squamous cell carcinoma) The size of the tumor. Whether the cancer has spread to nearby lymph nodes. Whether the cancer has spread to a different part of the body. Tumor grade, which refers to how abnormalthe cancer
IMMUNOTHERAPY FOR CANCER Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.. Immunotherapy is a type of biological therapy.Biological therapy is a type of treatment that uses substances made from living organisms to treat cancer. CORONAVIRUS VACCINES AND PEOPLE WITH CANCER Dr. Steven Pergam of the Fred Hutchinson Cancer Research Center discusses the importance of COVID-19 vaccination for people being treated for cancer and cancer survivors. This post was updated on April 9, 2021, with additional questions and answers. RADIATION THERAPY SIDE EFFECTS Radiation therapy has side effects because it not only kills or slows the growth of cancer cells, it can also affect nearby healthy cells. Many people who get radiation therapy experience fatigue. Other side effects depend on the part of the body that is being treated. Learn more about possible side effects. SIDE EFFECTS OF IMMUNOTHERAPY Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body. Learn about the types of side effects that immunotherapy might cause and where to go for more information. STEM CELL TRANSPLANTS IN CANCER TREATMENT Types of Stem Cell Transplants. In a stem cell transplant, you receive healthy blood-forming stem cells through a needle in your vein. Once they enter your bloodstream, the stem cells travel to the bone marrow, where they take the place of the cells that were destroyed by treatment.The blood-forming stem cells that are used in transplants can come from the bone marrow, bloodstream, or INFLAMMATORY BREAST CANCER Inflammatory breast cancer is a rare and very aggressive disease in which cancer cells block lymph vessels in the skin of the breast. This type of breast cancer is called “inflammatory” because the breast often looks swollen and red, or inflamed. Inflammatory breast cancer is rare, accounting for 1 to 5 percent of all breast cancers WHAT DOES MELANOMA LOOK LIKE? Melanoma is a type of cancer that begins in melanocytes (cells that make the pigment melanin).Below are photos of melanoma that formed on the skin. Melanoma can also start in the eye, the intestines, or other areas of the body with pigmented tissues.. Often the first sign of melanoma is a change in the shape, color, size, or feel of an existingmole.
ETHYLENE OXIDE
At room temperature, ethylene oxide is a flammable colorless gas with a sweet odor. It is used primarily to produce other chemicals, including antifreeze. In smaller amounts, ethylene oxide is used as a pesticide and a sterilizing agent. The ability of ethylene oxide to damage DNA makes it an effective sterilizing agent but also accountsfor
IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ weakened immunesystems.
CANCER STAGING
Most staging systems include information about: Where the tumor is located in the body. The cell type (such as, adenocarcinoma or squamous cell carcinoma) The size of the tumor. Whether the cancer has spread to nearby lymph nodes. Whether the cancer has spread to a different part of the body. Tumor grade, which refers to how abnormalthe cancer
IMMUNOTHERAPY FOR CANCER Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.. Immunotherapy is a type of biological therapy.Biological therapy is a type of treatment that uses substances made from living organisms to treat cancer. CORONAVIRUS VACCINES AND PEOPLE WITH CANCER Dr. Steven Pergam of the Fred Hutchinson Cancer Research Center discusses the importance of COVID-19 vaccination for people being treated for cancer and cancer survivors. This post was updated on April 9, 2021, with additional questions and answers. RADIATION THERAPY SIDE EFFECTS Radiation therapy has side effects because it not only kills or slows the growth of cancer cells, it can also affect nearby healthy cells. Many people who get radiation therapy experience fatigue. Other side effects depend on the part of the body that is being treated. Learn more about possible side effects. SIDE EFFECTS OF IMMUNOTHERAPY Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body. Learn about the types of side effects that immunotherapy might cause and where to go for more information. STEM CELL TRANSPLANTS IN CANCER TREATMENT Types of Stem Cell Transplants. In a stem cell transplant, you receive healthy blood-forming stem cells through a needle in your vein. Once they enter your bloodstream, the stem cells travel to the bone marrow, where they take the place of the cells that were destroyed by treatment.The blood-forming stem cells that are used in transplants can come from the bone marrow, bloodstream, or INFLAMMATORY BREAST CANCER Inflammatory breast cancer is a rare and very aggressive disease in which cancer cells block lymph vessels in the skin of the breast. This type of breast cancer is called “inflammatory” because the breast often looks swollen and red, or inflamed. Inflammatory breast cancer is rare, accounting for 1 to 5 percent of all breast cancers WHAT DOES MELANOMA LOOK LIKE? Melanoma is a type of cancer that begins in melanocytes (cells that make the pigment melanin).Below are photos of melanoma that formed on the skin. Melanoma can also start in the eye, the intestines, or other areas of the body with pigmented tissues.. Often the first sign of melanoma is a change in the shape, color, size, or feel of an existingmole.
ETHYLENE OXIDE
At room temperature, ethylene oxide is a flammable colorless gas with a sweet odor. It is used primarily to produce other chemicals, including antifreeze. In smaller amounts, ethylene oxide is used as a pesticide and a sterilizing agent. The ability of ethylene oxide to damage DNA makes it an effective sterilizing agent but also accountsfor
A TO Z LIST OF CANCER TYPES Alphabetical list of all cancers, with links to disease-specific and general information about treatment, coping, screening, prevention, clinical trials, and other topics. METASTATIC CANCER: WHEN CANCER SPREADS Metastatic cancer is cancer that spreads from its site of origin to another part of the body. Learn how cancer spreads, possible symptoms, common sites where cancer spreads, and how to find out about treatmentoptions.
END-OF-LIFE CARE
If a person can no longer swallow, offer ice chips. Keep their lips moist with lip balm and their mouth clean with a soft, damp cloth. Awareness: Near the end of life, people often have episodes of confusion or waking dreams. They may get confused about time, place, and the identity of loved ones. THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. RADIATION THERAPY SIDE EFFECTS Radiation therapy has side effects because it not only kills or slows the growth of cancer cells, it can also affect nearby healthy cells. Many people who get radiation therapy experience fatigue. Other side effects depend on the part of the body that is being treated. Learn more about possible side effects. STEM CELL TRANSPLANTS IN CANCER TREATMENT Types of Stem Cell Transplants. In a stem cell transplant, you receive healthy blood-forming stem cells through a needle in your vein. Once they enter your bloodstream, the stem cells travel to the bone marrow, where they take the place of the cells that were destroyed by treatment.The blood-forming stem cells that are used in transplants can come from the bone marrow, bloodstream, or SIDE EFFECTS OF IMMUNOTHERAPY Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body. Learn about the types of side effects that immunotherapy might cause and where to go for more information. MONOCLONAL ANTIBODIES Monoclonal antibodies can cause side effects, which can differ from person to person. The ones you may have and how they make you feel will depend on many factors, such as how healthy you are before treatment, your type of cancer, how advanced it is, the type FOLFIRI - NATIONAL CANCER INSTITUTE IRI. = Irinotecan Hydrochloride. Chemotherapy is often given as a combination of drugs. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways. Each of the drugs in this combination is approved by the Food and Drug Administration (FDA) to treat cancer or conditions related to cancer. COMMON MOLES, DYSPLASTIC NEVI, AND RISK OF MELANOMA Although anyone can develop melanoma, people with the following risk factors have an increased chance of melanoma ( 1 ): Having a dysplastic nevus. Having more than 50 common moles. Sunlight: Sunlight is a source of UV radiation, which causes skin damage that can lead to melanoma and other skin cancers. IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ CORONAVIRUS VACCINES AND PEOPLE WITH CANCER Dr. Steven Pergam of the Fred Hutchinson Cancer Research Center discusses the importance of COVID-19 vaccination for people being treated for cancer and cancer survivors. This post was updated on April 9, 2021, with additional questions THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. LESS TREATMENT FOR HPV-RELATED OROPHARYNGEAL CANCER But starting in the mid-1990s, that began to change—dramatically. By the early 2010s, approximately 70% of diagnoses of oropharyngeal cancer were in people, predominantly White men, between the ages of 40 and 60. The culprit: the human papillomavirus, or HPV. Mendelsohn’s cancer was HPV positive and now, at the age of 51, although he APPENDIX C: SITE SPECIFIC CODING MODULES Appendix C brings together the site-specific instructions needed to abstract a case, facilitating efficiency and accuracy. The site-specific coding modules include SEER Coding Guidelines, Extent of Disease, and Surgery of Primary Site codes. 1 New for 2021 are theSite
RASOPATHIES HOME
The RASopathies are a group of rare genetic syndromes caused by variants in genes of the Ras/mitogen-activated -protein kinase (Ras/MAPK) pathway. A RASopathy can be inherited from a parent with the condition, or it can show up in a child, without any family history of the condition. Although each individual syndrome is recognizable, the groupSUMMARY STAGE 2018
SEER HEMATOPOIETIC AND LYMPHOID NEOPLASM DATABASE Hematopoietic and Lymphoid Neoplasm Database. The Multiple Primaries Calculator was designed to be used with the coding manual. Follow the rules and workflow in the manual prior to using the calculator. Use the Multiple Primaries Calculator when the rules instruct you to do so. If you are working with cases diagnosed before 2010 use theICD-O-3
COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (CTCAE) The NCI Common Terminology Criteria for Adverse Events is a descriptive terminology which can be utilized for Adverse Event (AE)reporting. A
SEER*RSA
SEER*RSA. Welcome to the SEER*RSA (SEER Registrar Staging Assistant) website. This site is to be used by cancer registrars who abstract and code extent of disease information, and important site-specific predictive and prognostic factors. Instructional manuals are providedelsewhere .
IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ CORONAVIRUS VACCINES AND PEOPLE WITH CANCER Dr. Steven Pergam of the Fred Hutchinson Cancer Research Center discusses the importance of COVID-19 vaccination for people being treated for cancer and cancer survivors. This post was updated on April 9, 2021, with additional questions THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. LESS TREATMENT FOR HPV-RELATED OROPHARYNGEAL CANCER But starting in the mid-1990s, that began to change—dramatically. By the early 2010s, approximately 70% of diagnoses of oropharyngeal cancer were in people, predominantly White men, between the ages of 40 and 60. The culprit: the human papillomavirus, or HPV. Mendelsohn’s cancer was HPV positive and now, at the age of 51, although he APPENDIX C: SITE SPECIFIC CODING MODULES Appendix C brings together the site-specific instructions needed to abstract a case, facilitating efficiency and accuracy. The site-specific coding modules include SEER Coding Guidelines, Extent of Disease, and Surgery of Primary Site codes. 1 New for 2021 are theSite
RASOPATHIES HOME
The RASopathies are a group of rare genetic syndromes caused by variants in genes of the Ras/mitogen-activated -protein kinase (Ras/MAPK) pathway. A RASopathy can be inherited from a parent with the condition, or it can show up in a child, without any family history of the condition. Although each individual syndrome is recognizable, the groupSUMMARY STAGE 2018
SEER HEMATOPOIETIC AND LYMPHOID NEOPLASM DATABASE Hematopoietic and Lymphoid Neoplasm Database. The Multiple Primaries Calculator was designed to be used with the coding manual. Follow the rules and workflow in the manual prior to using the calculator. Use the Multiple Primaries Calculator when the rules instruct you to do so. If you are working with cases diagnosed before 2010 use theICD-O-3
COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (CTCAE) The NCI Common Terminology Criteria for Adverse Events is a descriptive terminology which can be utilized for Adverse Event (AE)reporting. A
SEER*RSA
SEER*RSA. Welcome to the SEER*RSA (SEER Registrar Staging Assistant) website. This site is to be used by cancer registrars who abstract and code extent of disease information, and important site-specific predictive and prognostic factors. Instructional manuals are providedelsewhere .
CORONAVIRUS: WHAT PEOPLE WITH CANCER SHOULD KNOW What is coronavirus, or COVID-19? Coronaviruses are a large family of viruses that are common in people and many different species of animals. SARS-CoV-2 is a novel (new) coronavirus that has caused a pandemic of respiratory disease named coronavirus disease 2019, which is abbreviated COVID-19.. If I have cancer now or had it in the past, am I at higher risk of severe illness from COVID-19? SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM SEER is an authoritative source for cancer statistics in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. COVID-19 ABSTRACTION GUIDANCE COVID-19 Abstraction Guidance. As the COVID-19 pandemic takes its course, evidence is developing that cancer survivors are disproportionally affected by the new disease, from an increased risk of poor outcomes if infected to new barriers and challenges to receiving oncology care. Identifying unusual changes and differencesin the patterns of
MONOCLONAL ANTIBODIES Monoclonal antibodies can cause side effects, which can differ from person to person. The ones you may have and how they make you feel will depend on many factors, such as how healthy you are before treatment, your type of cancer, how advanced it is, the type SIDE EFFECTS OF IMMUNOTHERAPY Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body. Learn about the types of side effects that immunotherapy might cause and where to go for more information. RADIATION THERAPY SIDE EFFECTS Radiation therapy has side effects because it not only kills or slows the growth of cancer cells, it can also affect nearby healthy cells. Many people who get radiation therapy experience fatigue. Other side effects depend on the part of the body that is being treated. Learn more about possible side effects. FOLFIRINOX - NATIONAL CANCER INSTITUTE Drugs in the FOLFIRINOX combination: Chemotherapy is often given as a combination of drugs. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways. Each of the drugs in this combination is approved by the Food and Drug Administration (FDA) to treat cancer or conditions related to cancer.CANCER.GOV
cancer.gov
GDC
GDC Applications. The GDC Data Portal is a robust data-driven platform that allows cancer. researchers and bioinformaticians to search and download cancer data for analysis. The GDC applications include: DataPortal. Website.
ETHYLENE OXIDE
At room temperature, ethylene oxide is a flammable colorless gas with a sweet odor. It is used primarily to produce other chemicals, including antifreeze. In smaller amounts, ethylene oxide is used as a pesticide and a sterilizing agent. The ability of ethylene oxide to damage DNA makes it an effective sterilizing agent but also accountsfor
IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ CORONAVIRUS VACCINES AND PEOPLE WITH CANCER Dr. Steven Pergam of the Fred Hutchinson Cancer Research Center discusses the importance of COVID-19 vaccination for people being treated for cancer and cancer survivors. This post was updated on April 9, 2021, with additional questions THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. LESS TREATMENT FOR HPV-RELATED OROPHARYNGEAL CANCER But starting in the mid-1990s, that began to change—dramatically. By the early 2010s, approximately 70% of diagnoses of oropharyngeal cancer were in people, predominantly White men, between the ages of 40 and 60. The culprit: the human papillomavirus, or HPV. Mendelsohn’s cancer was HPV positive and now, at the age of 51, although he APPENDIX C: SITE SPECIFIC CODING MODULES Appendix C brings together the site-specific instructions needed to abstract a case, facilitating efficiency and accuracy. The site-specific coding modules include SEER Coding Guidelines, Extent of Disease, and Surgery of Primary Site codes. 1 New for 2021 are theSite
RASOPATHIES HOME
The RASopathies are a group of rare genetic syndromes caused by variants in genes of the Ras/mitogen-activated -protein kinase (Ras/MAPK) pathway. A RASopathy can be inherited from a parent with the condition, or it can show up in a child, without any family history of the condition. Although each individual syndrome is recognizable, the groupSUMMARY STAGE 2018
SEER HEMATOPOIETIC AND LYMPHOID NEOPLASM DATABASE Hematopoietic and Lymphoid Neoplasm Database. The Multiple Primaries Calculator was designed to be used with the coding manual. Follow the rules and workflow in the manual prior to using the calculator. Use the Multiple Primaries Calculator when the rules instruct you to do so. If you are working with cases diagnosed before 2010 use theICD-O-3
COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (CTCAE) The NCI Common Terminology Criteria for Adverse Events is a descriptive terminology which can be utilized for Adverse Event (AE)reporting. A
SEER*RSA
SEER*RSA. Welcome to the SEER*RSA (SEER Registrar Staging Assistant) website. This site is to be used by cancer registrars who abstract and code extent of disease information, and important site-specific predictive and prognostic factors. Instructional manuals are providedelsewhere .
IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ CORONAVIRUS VACCINES AND PEOPLE WITH CANCER Dr. Steven Pergam of the Fred Hutchinson Cancer Research Center discusses the importance of COVID-19 vaccination for people being treated for cancer and cancer survivors. This post was updated on April 9, 2021, with additional questions THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. LESS TREATMENT FOR HPV-RELATED OROPHARYNGEAL CANCER But starting in the mid-1990s, that began to change—dramatically. By the early 2010s, approximately 70% of diagnoses of oropharyngeal cancer were in people, predominantly White men, between the ages of 40 and 60. The culprit: the human papillomavirus, or HPV. Mendelsohn’s cancer was HPV positive and now, at the age of 51, although he APPENDIX C: SITE SPECIFIC CODING MODULES Appendix C brings together the site-specific instructions needed to abstract a case, facilitating efficiency and accuracy. The site-specific coding modules include SEER Coding Guidelines, Extent of Disease, and Surgery of Primary Site codes. 1 New for 2021 are theSite
RASOPATHIES HOME
The RASopathies are a group of rare genetic syndromes caused by variants in genes of the Ras/mitogen-activated -protein kinase (Ras/MAPK) pathway. A RASopathy can be inherited from a parent with the condition, or it can show up in a child, without any family history of the condition. Although each individual syndrome is recognizable, the groupSUMMARY STAGE 2018
SEER HEMATOPOIETIC AND LYMPHOID NEOPLASM DATABASE Hematopoietic and Lymphoid Neoplasm Database. The Multiple Primaries Calculator was designed to be used with the coding manual. Follow the rules and workflow in the manual prior to using the calculator. Use the Multiple Primaries Calculator when the rules instruct you to do so. If you are working with cases diagnosed before 2010 use theICD-O-3
COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (CTCAE) The NCI Common Terminology Criteria for Adverse Events is a descriptive terminology which can be utilized for Adverse Event (AE)reporting. A
SEER*RSA
SEER*RSA. Welcome to the SEER*RSA (SEER Registrar Staging Assistant) website. This site is to be used by cancer registrars who abstract and code extent of disease information, and important site-specific predictive and prognostic factors. Instructional manuals are providedelsewhere .
CORONAVIRUS: WHAT PEOPLE WITH CANCER SHOULD KNOW What is coronavirus, or COVID-19? Coronaviruses are a large family of viruses that are common in people and many different species of animals. SARS-CoV-2 is a novel (new) coronavirus that has caused a pandemic of respiratory disease named coronavirus disease 2019, which is abbreviated COVID-19.. If I have cancer now or had it in the past, am I at higher risk of severe illness from COVID-19? SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM SEER is an authoritative source for cancer statistics in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. COVID-19 ABSTRACTION GUIDANCE COVID-19 Abstraction Guidance. As the COVID-19 pandemic takes its course, evidence is developing that cancer survivors are disproportionally affected by the new disease, from an increased risk of poor outcomes if infected to new barriers and challenges to receiving oncology care. Identifying unusual changes and differencesin the patterns of
MONOCLONAL ANTIBODIES Monoclonal antibodies can cause side effects, which can differ from person to person. The ones you may have and how they make you feel will depend on many factors, such as how healthy you are before treatment, your type of cancer, how advanced it is, the type SIDE EFFECTS OF IMMUNOTHERAPY Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body. Learn about the types of side effects that immunotherapy might cause and where to go for more information. RADIATION THERAPY SIDE EFFECTS Radiation therapy has side effects because it not only kills or slows the growth of cancer cells, it can also affect nearby healthy cells. Many people who get radiation therapy experience fatigue. Other side effects depend on the part of the body that is being treated. Learn more about possible side effects. FOLFIRINOX - NATIONAL CANCER INSTITUTE Drugs in the FOLFIRINOX combination: Chemotherapy is often given as a combination of drugs. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways. Each of the drugs in this combination is approved by the Food and Drug Administration (FDA) to treat cancer or conditions related to cancer.CANCER.GOV
cancer.gov
GDC
GDC Applications. The GDC Data Portal is a robust data-driven platform that allows cancer. researchers and bioinformaticians to search and download cancer data for analysis. The GDC applications include: DataPortal. Website.
ETHYLENE OXIDE
At room temperature, ethylene oxide is a flammable colorless gas with a sweet odor. It is used primarily to produce other chemicals, including antifreeze. In smaller amounts, ethylene oxide is used as a pesticide and a sterilizing agent. The ability of ethylene oxide to damage DNA makes it an effective sterilizing agent but also accountsfor
IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ CORONAVIRUS VACCINES AND PEOPLE WITH CANCER Dr. Steven Pergam of the Fred Hutchinson Cancer Research Center discusses the importance of COVID-19 vaccination for people being treated for cancer and cancer survivors. This post was updated on April 9, 2021, with additional questions THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. LESS TREATMENT FOR HPV-RELATED OROPHARYNGEAL CANCER Then came the emergence of robotic surgery. A form of minimally invasive surgery, robotic surgery usually requires just a few small incisions, into which a tiny camera and robotic arms with wrist-like appendages that can wield surgical instruments are inserted.The surgeon controls these components from a console in the operating room. But unlike robotic surgery for other procedures, for SEER HEMATOPOIETIC AND LYMPHOID NEOPLASM DATABASE SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS).SRP provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population-basedstatistics.
APPENDIX C: SITE SPECIFIC CODING MODULES Appendix C brings together the site-specific instructions needed to abstract a case, facilitating efficiency and accuracy. The site-specific coding modules include SEER Coding Guidelines, Extent of Disease, and Surgery of Primary Site codes. 1 New for 2021 are theSite
BREAST CANCER RISK ASSESSMENT TOOL This tool cannot accurately calculate risk for women with a medical history of breast cancer, DCIS or LCIS. Other tools may be more appropriate for women with known mutations in either the BRCA1 or BRCA2 gene, or other hereditary syndromes associated with higher risks of breast cancer. See Other Risk Assessment Tools for moreinformation.
SEER*RSA
Welcome to the SEER*RSA (SEER Registrar Staging Assistant) website. This site is to be used by cancer registrars who abstract and code extent of disease information, and important site-specific predictive and prognostic factors.SUMMARY STAGE 2018
COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (CTCAE) The NCI Common Terminology Criteria for Adverse Events is a descriptive terminology which can be utilized for Adverse Event (AE)reporting. A
IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ CORONAVIRUS VACCINES AND PEOPLE WITH CANCER Dr. Steven Pergam of the Fred Hutchinson Cancer Research Center discusses the importance of COVID-19 vaccination for people being treated for cancer and cancer survivors. This post was updated on April 9, 2021, with additional questions THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. LESS TREATMENT FOR HPV-RELATED OROPHARYNGEAL CANCER Then came the emergence of robotic surgery. A form of minimally invasive surgery, robotic surgery usually requires just a few small incisions, into which a tiny camera and robotic arms with wrist-like appendages that can wield surgical instruments are inserted.The surgeon controls these components from a console in the operating room. But unlike robotic surgery for other procedures, for SEER HEMATOPOIETIC AND LYMPHOID NEOPLASM DATABASE SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS).SRP provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population-basedstatistics.
APPENDIX C: SITE SPECIFIC CODING MODULES Appendix C brings together the site-specific instructions needed to abstract a case, facilitating efficiency and accuracy. The site-specific coding modules include SEER Coding Guidelines, Extent of Disease, and Surgery of Primary Site codes. 1 New for 2021 are theSite
BREAST CANCER RISK ASSESSMENT TOOL This tool cannot accurately calculate risk for women with a medical history of breast cancer, DCIS or LCIS. Other tools may be more appropriate for women with known mutations in either the BRCA1 or BRCA2 gene, or other hereditary syndromes associated with higher risks of breast cancer. See Other Risk Assessment Tools for moreinformation.
SEER*RSA
Welcome to the SEER*RSA (SEER Registrar Staging Assistant) website. This site is to be used by cancer registrars who abstract and code extent of disease information, and important site-specific predictive and prognostic factors.SUMMARY STAGE 2018
COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (CTCAE) The NCI Common Terminology Criteria for Adverse Events is a descriptive terminology which can be utilized for Adverse Event (AE)reporting. A
CORONAVIRUS VACCINES AND PEOPLE WITH CANCER Dr. Steven Pergam of the Fred Hutchinson Cancer Research Center discusses the importance of COVID-19 vaccination for people being treated for cancer and cancer survivors. This post was updated on April 9, 2021, with additional questions THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. RADIATION THERAPY SIDE EFFECTS Radiation therapy has side effects because it not only kills or slows the growth of cancer cells, it can also affect nearby healthy cells. Many people who get radiation therapy experience fatigue. Other side effects depend on the part of the body that is being treated. Learn more about possible side effects. LESS TREATMENT FOR HPV-RELATED OROPHARYNGEAL CANCER Then came the emergence of robotic surgery. A form of minimally invasive surgery, robotic surgery usually requires just a few small incisions, into which a tiny camera and robotic arms with wrist-like appendages that can wield surgical instruments are inserted.The surgeon controls these components from a console in the operating room. But unlike robotic surgery for other procedures, for CAR T-CELL THERAPY APPROVED FOR MULTIPLE MYELOMA A type of immunotherapy called CAR T-cell therapy is now an option for some people with multiple myeloma.On March 26, the Food and Drug Administration (FDA) approved idecabtagene vicleucel (Abecma) for people with multiple myeloma that has not responded to or has returned after at least four different prior cancer treatments.. Multiple myeloma is a type of cancer that occurs whenCANCER.GOV
cancer.gov
SITE RECODE
The values of SEER site recode variables are based on the primary site and histology data fields submitted to SEER by the registries. The site recode variables define the major cancer site/histology groups that are commonly used in SEER's reporting of cancer incidence data and published statistics.GDC
We detected you are using Internet Explorer. This site is best viewed with Chrome, Edge, or Firefox. HOME - SEER INQUIRY SYSTEM The SEER Inquiry System (SINQ) is a searchable collection of questions that cancer registrars have had while coding cancer cases. These are questions submitted by designated registrars in SEER registries.SUMMARY STAGE 2018
Access this manual of codes and coding instructions for the summary stage field for cases diagnosed January 1, 2018 and forward. 2018 version applies to every anatomic site. It uses all information in the medical record. Also called General Staging, California Staging, andSEER Staging.
COMPREHENSIVE CANCER INFORMATION Accurate, up-to-date, comprehensive cancer information from the U.S. government's principal agency for cancer research. IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ weakened immunesystems.
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM SEER is an authoritative source for cancer statistics in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. WHAT DOES MELANOMA LOOK LIKE? Melanoma is a type of cancer that begins in melanocytes (cells that make the pigment melanin).Below are photos of melanoma that formed on the skin. Melanoma can also start in the eye, the intestines, or other areas of the body with pigmented tissues.. Often the first sign of melanoma is a change in the shape, color, size, or feel of an existingmole.
SUPPORT FOR PEOPLE WITH CANCER: CANCER PAIN CONTROL Cancer Pain Control. Cancer pain can be managed. Having cancer doesn’t mean that you’ll have pain. But if you do, you can manage most of your pain with medicine and other treatments.ETHYLENE OXIDE
At room temperature, ethylene oxide is a flammable colorless gas with a sweet odor. It is used primarily to produce other chemicals, including antifreeze. In smaller amounts, ethylene oxide is used as a pesticide and a sterilizing agent. The ability of ethylene oxide to damage DNA makes it an effective sterilizing agent but also accountsfor
CANCER THERAPY EVALUATION PROGRAM (CTEP) About the Associate Director. Meg Mooney, MD, MS, is the CTEP Associate Director where she has oversight and coordination responsibilities for the programmatic, financial, and administrative functions for the entire CTEP program, which covers a broad, multidisciplinary, clinical research effort to coordinate nationwide phase 1-3 clinical trials programs testing new treatment approachesfor cancer.
PROSTATE-SPECIFIC ANTIGEN (PSA) TEST Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.SEER*RSA
SEER*RSA. Welcome to the SEER*RSA (SEER Registrar Staging Assistant) website. This site is to be used by cancer registrars who abstract and code extent of disease information, and important site-specific predictive and prognostic factors. Instructional manuals are providedelsewhere .
COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (CTCAE) The NCI Common Terminology Criteria for Adverse Events is a descriptive terminology which can be utilized for Adverse Event (AE)reporting. A
COMPREHENSIVE CANCER INFORMATION Accurate, up-to-date, comprehensive cancer information from the U.S. government's principal agency for cancer research. IN PEOPLE WITH CANCER, RESPONSES TO COVID-19 VACCINES VARY People with blood cancers seem to be less protected by COVID-19 vaccines than those with other types of cancer and people without cancer, three new studies suggest. Experts believe the vaccines’ limited effectiveness is likely due to patients’ weakened immunesystems.
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM SEER is an authoritative source for cancer statistics in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. WHAT DOES MELANOMA LOOK LIKE? Melanoma is a type of cancer that begins in melanocytes (cells that make the pigment melanin).Below are photos of melanoma that formed on the skin. Melanoma can also start in the eye, the intestines, or other areas of the body with pigmented tissues.. Often the first sign of melanoma is a change in the shape, color, size, or feel of an existingmole.
SUPPORT FOR PEOPLE WITH CANCER: CANCER PAIN CONTROL Cancer Pain Control. Cancer pain can be managed. Having cancer doesn’t mean that you’ll have pain. But if you do, you can manage most of your pain with medicine and other treatments.ETHYLENE OXIDE
At room temperature, ethylene oxide is a flammable colorless gas with a sweet odor. It is used primarily to produce other chemicals, including antifreeze. In smaller amounts, ethylene oxide is used as a pesticide and a sterilizing agent. The ability of ethylene oxide to damage DNA makes it an effective sterilizing agent but also accountsfor
CANCER THERAPY EVALUATION PROGRAM (CTEP) About the Associate Director. Meg Mooney, MD, MS, is the CTEP Associate Director where she has oversight and coordination responsibilities for the programmatic, financial, and administrative functions for the entire CTEP program, which covers a broad, multidisciplinary, clinical research effort to coordinate nationwide phase 1-3 clinical trials programs testing new treatment approachesfor cancer.
PROSTATE-SPECIFIC ANTIGEN (PSA) TEST Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.SEER*RSA
SEER*RSA. Welcome to the SEER*RSA (SEER Registrar Staging Assistant) website. This site is to be used by cancer registrars who abstract and code extent of disease information, and important site-specific predictive and prognostic factors. Instructional manuals are providedelsewhere .
COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (CTCAE) The NCI Common Terminology Criteria for Adverse Events is a descriptive terminology which can be utilized for Adverse Event (AE)reporting. A
COMPREHENSIVE CANCER INFORMATION Accurate, up-to-date, comprehensive cancer information from the U.S. government's principal agency for cancer research. A TO Z LIST OF CANCER TYPES Alphabetical list of all cancers, with links to disease-specific and general information about treatment, coping, screening, prevention, clinical trials, and other topics. THE CANCER GENOME ATLAS PROGRAM The Cancer Genome Atlas (TCGA) is a landmark cancer genomics program that sequenced and molecularly characterized over 11,000 cases of primary cancer samples. Learn more about how the program transformed the cancer research community and beyond. LAST DAYS OF LIFE (PDQ®)–PATIENT VERSION The last days of life for patients with cancer can involve a wide range of possible symptoms and ethical dilemmas. Learn about issues like delirium, fatigue, breathing and swallowing problems, constipation, muscle twitching, fever, bleeding, pain, and more in this expert-reviewed summary. SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM SEER is an authoritative source for cancer statistics in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. INFLAMMATORY BREAST CANCER Inflammatory breast cancer is a rare and very aggressive disease in which cancer cells block lymph vessels in the skin of the breast. This type of breast cancer is called “inflammatory” because the breast often looks swollen and red, or inflamed. Inflammatory breast cancer is rare, accounting for 1 to 5 percent of all breast cancersCANCER.GOV
cancer.gov
SUPPORT FOR PEOPLE WITH CANCER: CANCER PAIN CONTROL Cancer Pain Control. Cancer pain can be managed. Having cancer doesn’t mean that you’ll have pain. But if you do, you can manage most of your pain with medicine and other treatments.ETHYLENE OXIDE
At room temperature, ethylene oxide is a flammable colorless gas with a sweet odor. It is used primarily to produce other chemicals, including antifreeze. In smaller amounts, ethylene oxide is used as a pesticide and a sterilizing agent. The ability of ethylene oxide to damage DNA makes it an effective sterilizing agent but also accountsfor
SEER*RSA
SEER*RSA. Welcome to the SEER*RSA (SEER Registrar Staging Assistant) website. This site is to be used by cancer registrars who abstract and code extent of disease information, and important site-specific predictive and prognostic factors. Instructional manuals are providedelsewhere .
Skip to main content * " class="es">">Español 1-800-4-CANCER Live Chat Publications Dictionary MenuContact DictionarySearch
*
About Cancer Expand*
Understanding Cancer Expand*
What Is Cancer?
*
Cancer Statistics
*
Cancer Disparities
*
Cancer Causes and Prevention Expand*
Risk Factors
*
Genetics
*
Cancer Prevention Overview*
Research
*
Cancer Screening Expand*
Cancer Screening Overview*
Screening Tests
*
Research
*
Diagnosis and Staging Expand*
Symptoms
*
Diagnosis
*
Staging
*
Prognosis
*
Questions to Ask about Your Diagnosis*
Research
*
Cancer Treatment Expand*
Types of Cancer Treatment*
Side Effects of Cancer Treatment*
Clinical Trials Information*
A to Z List of Cancer Drugs*
Complementary & Alternative Medicine (CAM)*
Questions to Ask about Your Treatment*
Research
*
Coping with Cancer Expand*
Feelings and Cancer
*
Adjusting to Cancer
*
Self-Image & Sexuality*
Day-to-Day Life
*
Support for Caregivers*
Survivorship
*
Questions to Ask About Cancer*
Research
*
Advanced Cancer Expand*
Choices for Care
*
Talking about Your Advanced Cancer*
Coping with Your Feelings During Advanced Cancer*
Planning for Advanced Cancer*
Advanced Cancer and Caregivers*
Questions to Ask about Advanced Cancer*
Research
*
Managing Cancer Care Expand*
Finding Health Care Services*
Costs & Medical Information*
Advance Directives
*
Using Trusted Resources * Understanding Cancer* What Is Cancer
* Cancer Statistics
* Cancer Disparities * Causes & Prevention* Risk Factors
* Genetics
* Cancer Prevention Overview* Screening
* Cancer Screening Overview* Screening Tests
* Diagnosis & Staging* Symptoms
* Diagnosis
* Staging
* Prognosis
* Treatment
* Types of Treatment* Side Effects
* Clinical Trials
* Cancer Drugs
* Complementary & Alternative Medicine* Coping
* Feelings & Cancer
* Adjusting to Cancer * Self Image & Sexuality* Day to Day Life
* Survivorship
* Support for Caregivers * Questions to Ask About Cancer* Advanced Cancer
* Choices For Care
* Talking About Advanced Cancer * Coping With Your Feelings * Planning for Advanced Cancer * Advanced Cancer & Caregivers * Managing Cancer Care * Finding Health Care Services * Managing Costs and Medical Information * Advance Directives * Using Trusted ResourcesExpand
*
Cancer Types Expand*
Adolescents and Young Adults with Cancer Expand*
Reports, Research, and Literature*
Cancers by Body Location*
Childhood Cancers Expand*
Late Effects of Childhood Cancer Treatment*
Pediatric Supportive Care*
Unusual Cancers of Childhood Treatment*
Childhood Cancer Genomics*
Study Findings
*
Metastatic Cancer Expand*
Metastatic Cancer Research*
Common Cancer Types
*
Recurrent Cancer
* Common Cancer Types* Bladder Cancer
* Breast Cancer
* Colorectal Cancer
* Kidney (Renal Cell) Cancer* Leukemia
* Liver Cancer
* Lung Cancer
* Lymphoma
* Pancreatic Cancer
* Prostate Cancer
* Skin Cancer
* Thyroid Cancer
* Uterine Cancer
* All Cancer Types
* A to Z List of Cancers * Cancers by Body Location* Childhood Cancers
* Adolescent & Young Adult Cancers* Metastatic Cancer
* Recurrent Cancer
Expand
*
Research Expand
*
NCI’s Role in Cancer Research Expand*
Intramural Research
*
Extramural Research
*
Bioinformatics, Big Data, and Cancer*
NCI-Designated Cancer Centers*
Frederick National Laboratory for Cancer Research*
Partners & Collaborators*
Spotlight on Scientists*
Research Areas Expand*
Cancer Biology Research*
Cancer Genomics Research*
Research on Causes of Cancer*
Cancer Diagnosis Research*
Cancer Prevention Research*
Screening & Early Detection*
Cancer Treatment Research*
Cancer & Public Health*
Cancer Health Disparities*
Childhood Cancers Research*
Clinical Trials Research*
Global Cancer Research*
Key Initiatives
*
Progress Expand
*
Annual Report to the Nation*
Research Advances by Cancer Type*
Stories of Discovery*
Milestones in Cancer Research and Discovery*
Resources for Researchers Expand*
Cryo-EM
*
Terminology Resources * NCI's Role in Cancer Research * Intramural Research * Extramural Research * Bioinformatics & Big Data * NCI-Designated Cancer Centers * Frederick National Lab * Partners & Collaborators * Spotlight on Scientists * NCI Research Areas* Cancer Biology
* Cancer Genomics
* Causes of Cancer
* Diagnosis
* Prevention
* Screening & Early Detection* Treatment
* Cancer & Public Health * Cancer Health Disparities* Childhood Cancer
* Clinical Trials
* Global Health
* Key Initiatives
* Cancer Moonshot
* Childhood Cancer Data Initiative * Genomic Data Commons * National Clinical Trials Network* RAS Initiative
* Progress
* Annual Report to the Nation * Research Advances by Cancer Type * Stories of Discovery * Resources for ResearchersExpand
*
Grants & Training Expand*
Research Grants Expand*
Research Funding Opportunities*
Research Program Contacts*
Funding Strategy
*
Grants Policies and ProcessExpand
*
Introduction to Grants Process*
NCI Grant Policies
*
Legal Requirements
*
Apply for a Grant Expand*
Step 1: Application Development & Submission*
Step 2: Application Receipt & Assignment*
Step 3: Peer Review and Funding Outcomes*
Step 4: Award Negotiation & Issuance*
Manage Your Award Expand*
Grants Management Contacts*
Monitoring
*
Prior Approvals
*
Annual Reporting and Auditing*
Transfer of a Grant
*
Grant Closeout
*
Training Expand
*
Cancer Training at NCI*
Resources for Trainees*
Funding for Cancer Training*
Building a Diverse Workforce*
About Center for Cancer Training (CCT)*
CCT Staff & Contact
*
NCI Bottom Line Blog* Research Grants
* Funding Opportunities * Research Program Contacts* Funding Strategy
* Grants Policies & Process * Introduction to Grants Process* NCI Policies
* Legal Requirements* Apply for a Grant
* Application Development & Submission * Receipt & Assignment * Peer Review & Outcomes* Award Issuance
* Manage Your Award
* Grants Management Contacts* Monitoring
* Prior Approvals
* Annual Reporting & Auditing * Transfer of a Grant* Grant Closeout
* Contracts & Small Business* Training
* Cancer Training at NCI (Intramural) * Resources for Trainees * Funding for Cancer Training (Extramural) * Building a Diverse Workforce * Training Program Contacts * NCI Bottom Line BlogExpand
*
News & Events Expand*
News Releases
*
Resources for News Media Expand*
Media Contacts
*
Cancer Reporting Fellowships*
Events Expand
*
Scientific Meetings & Lectures*
Conferences
*
Advisory Board Meetings*
Social Media Events
*
Cancer Currents Blog* All News Releases
* 2020
* 2019
* 2018
* 2017
* 2016
* 2015
* Media Resources
* Media Contacts
* Events
* Scientific Meetings & Lectures* Conferences
* Advisory Board Meetings* Social Media
* Cancer Currents BlogExpand
*
About NCI Expand
*
NCI Overview Expand*
History
*
Contributing to Cancer Research*
Strategic Planning
*
Leadership Expand
*
Director's Page
*
Deputy Director's Page*
Previous NCI Directors*
NCI Organization
*
Advisory Boards and Review Groups*
Budget & Appropriations Expand*
About the Annual Plan & Budget Proposal*
NCI Congressional Justification*
NCI Budget Fact Book*
Careers at NCI
*
Visitor Information
*
Legislative Activities Expand*
Hearings & Testimonies*
Current Congress
*
Committees of Interest*
Legislative Resources*
Recent Public Laws
*
Contact
* Overview & Mission* History of NCI
* Contributing to Cancer Research * Strategic Planning at NCI* Senior Leadership
* Director
* Principal Deputy Director * Previous Directors* NCI Organization
* Divisions, Offices & Centers * Advisory Boards & Review Groups * Budget & Appropriations * Current Year Budget * Annual Plan & Budget Proposal * Congressional Justification * NCI Budget Fact Book * Legislative Activities * Hearings & Testimonies* Current Congress
* Committees of Interest * Legislative Resources * Recent Public Laws* Contracts
* Careers
* Visitor InformationExpand
Search Search
NCI is the nation's leader in cancer research*
*
*
*
*
Find a Clinical TrialFEATURED CONTENT
THE CANCER MOONSHOT This broad-based effort is making new investments to accelerate progress against cancer. LEARN ABOUT COLORECTAL CANCER Finding and treating colorectal cancer early may prevent death from this disease. Learn more from these evidence-based resources.RARE CANCERS
A quarter of all cancer deaths each year are due to rare cancers. Although new treatments are always being developed, finding new treatments for rare cancers is challenging. CANCER RESEARCH RESOURCES * Funding Opportunities* Funding Strategy
* Apply for a Grant
* Manage Your Award
* Training at NCI
* Funding for Cancer Training * Resources for Researchers * Find more research resourcesABOUT CANCER
* What is Cancer
* Causes & Prevention * Diagnosis & Staging* Prognosis
* Cancer Treatment
* Cancer Treatment Side Effects * Find a Clinical Trial* Cancer Statistics
* Coping with Cancer * Learn more about cancerFIND A CANCER TYPE
* Breast Cancer
* Childhood Cancers
* Colorectal Cancer
* Leukemia
* Lung Cancer
* Lymphoma
* Metastatic Cancer
* Pancreatic Cancer
* Prostate Cancer
* View all cancer typesFOLLOW US
TWITTER EXIT DISCLAIMER FACEBOOK EXIT DISCLAIMER LINKEDIN EXIT DISCLAIMERINSTAGRAM EXIT
DISCLAIMER
Paying for Clinical Trials Learn about the different types of costs related to taking part in a clinical trial, and who is expected to pay for which costs.SENIOR LEADERS
Information about NCI Director Norman E. Sharpless, M.D., and othersenior NCI leaders.
*
RESOURCES FOR YOU
Find information and resources that fit your needs as a patient, caregiver, health professional, researcher, or other visitor. NCI DIVISIONS, OFFICES, AND CENTERSPrevious Next
Coordinating Center for Clinical TrialsVisit CCCT Site
SBIR Development CenterVisit SBIR Site
Technology Transfer CenterVisit TTC Site
Frederick National Laboratory for Cancer ResearchVisit FNLCR Site
Center for Cancer ResearchVisit CCR Site
Division of Cancer BiologyVisit DCB Site
Division of Cancer Control and Population SciencesVisit DCCPS Site
Division of Cancer Epidemiology and GeneticsVisit DCEG Site
Division of Cancer PreventionVisit DCP Site
Division of Cancer Treatment and DiagnosisVisit DCTD Site
Division of Extramural ActivitiesVisit DEA Site
Center for Cancer TrainingVisit CCT Site
Center for Cancer GenomicsVisit CCG Site
Center for Global HealthVisit CGH Site
Center to Reduce Cancer Health DisparitiesVisit CRCHD Site
Center for Biomedical Informatics and Information TechnologyVisit CBIIT Site
Center for Strategic Scientific InitiativesVisit CSSI Site
Coordinating Center for Clinical TrialsVisit CCCT Site
SBIR Development CenterVisit SBIR Site
Technology Transfer CenterVisit TTC Site
Frederick National Laboratory for Cancer ResearchVisit FNLCR Site
Center for Cancer ResearchVisit CCR Site
Division of Cancer BiologyVisit DCB Site
Division of Cancer Control and Population SciencesVisit DCCPS Site
Division of Cancer Epidemiology and GeneticsVisit DCEG Site
Division of Cancer PreventionVisit DCP Site
Division of Cancer Treatment and DiagnosisVisit DCTD Site
Division of Extramural ActivitiesVisit DEA Site
Center for Cancer TrainingVisit CCT Site
Center for Cancer GenomicsVisit CCG Site
Center for Global HealthVisit CGH Site
Center to Reduce Cancer Health DisparitiesVisit CRCHD Site
Center for Biomedical Informatics and Information TechnologyVisit CBIIT Site
Center for Strategic Scientific InitiativesVisit CSSI Site
Coordinating Center for Clinical TrialsVisit CCCT Site
SBIR Development CenterVisit SBIR Site
Technology Transfer CenterVisit TTC Site
Frederick National Laboratory for Cancer ResearchVisit FNLCR Site
* 1
* 2
* 3
* 4
* 5
NATIONAL CANCER INSTITUTE AT THE NATIONAL INSTITUTES OF HEALTHFOLLOW US
* YouTube
* GovDelivery
* RSS
CONTACT INFORMATION
* Contact Us
* LiveHelp Online ChatMORE INFORMATION
* About This Website * Cancer.gov en español* Multimedia
* Publications
* Site Map
* Digital Standards for NCI WebsitesPOLICIES
* Accessibility
* Comment Policy
* Disclaimer
* FOIA
* Privacy & Security* Reuse & Copyright
* Syndication Services* Website Linking
* U.S. Department of Health and Human Services * National Institutes of Health * National Cancer Institute* USA.gov
NIH ... TURNING DISCOVERY INTO HEALTH ®TOP
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0